Source: Journal of surgical oncology. Unidade: FM
Subjects: ESTUDOS RETROSPECTIVOS, PROGNÓSTICO, NEUTRÓFILOS, HEMOGLOBINAS, TESTES HEMATOLÓGICOS, NEOPLASIAS ESOFÁGICAS, ESTUDOS DE COORTES, ADENOCARCINOMA
ABNT
TUSTUMI, Francisco et al. The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer. Journal of surgical oncology, v. 121, n. 5, p. 784-794, 2020Tradução . . Disponível em: https://doi.org/10.1002/jso.25778. Acesso em: 05 out. 2024.APA
Tustumi, F., Takeda, F. R., Viyuela, M. S., Cruz Junior, J. B. da, Brandao, A. A. G. S., Sallum, R. A. A., et al. (2020). The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer. Journal of surgical oncology, 121( 5), 784-794. doi:10.1002/jso.25778NLM
Tustumi F, Takeda FR, Viyuela MS, Cruz Junior JB da, Brandao AAGS, Sallum RAA, Ribeiro Junior U, Cecconello I. The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 784-794.[citado 2024 out. 05 ] Available from: https://doi.org/10.1002/jso.25778Vancouver
Tustumi F, Takeda FR, Viyuela MS, Cruz Junior JB da, Brandao AAGS, Sallum RAA, Ribeiro Junior U, Cecconello I. The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 784-794.[citado 2024 out. 05 ] Available from: https://doi.org/10.1002/jso.25778